Guilin Royalyze Medical launches a multi parameter intelligent blood glucose meter that can accurately measure glucose in 5 seconds and also detect uric acid


Release time:

2025-10-27

In the wave of intelligent home blood glucose meters, Guilin Royalyze Medical Equipment Co., Ltd. (hereinafter referred to as Royalyze Medical") recently upgraded and launched a new generation of Bluetooth intelligent blood glucose meters, which has attracted industry attention with its "fast, accurate, and comprehensive" technological advantages. This detection device equipped with Bluetooth 4.0 module not only realizes the convenient experience of 5 seconds of results and 1 microliter of micro blood collection, but also is compatible with the detection of blood glucose and uric acid, providing one-stop monitoring solutions for patients with diabetes combined with hyperuricemia. ​

In the wave of intelligent home blood glucose meters, Guilin Royalyze Medical Equipment Co., Ltd. (hereinafter referred to as Royalyze Medical") recently upgraded and launched a new generation of Bluetooth intelligent blood glucose meters, which has attracted industry attention with its "fast, accurate, and comprehensive" technological advantages. This detection device equipped with Bluetooth 4.0 module not only realizes the convenient experience of 5 seconds of results and 1 microliter of micro blood collection, but also is compatible with the detection of blood glucose and uric acid, providing one-stop monitoring solutions for patients with diabetes combined with hyperuricemia. ​
As an established enterprise with ISO13485 certification and multiple patents,
Guilin Royalyze Medical has achieved a key breakthrough in core technology: the blood glucose meter uses a unique anti hematocrit material formula with a dedicated test strip, combined with a built-in impedance recognition program. Long term use does not require calibration, and the detection accuracy is only one unit lower than that of hospital professional equipment. More noteworthy is that the device can transmit data to a mobile app via Bluetooth over a distance of 100 meters, automatically generating 7-day, 14 day, and 28 day blood glucose mean reports. Its accompanying AI health management system can provide dietary recommendations based on millions of clinical data, truly achieving a "monitoring analysis intervention" loop. ​
This product solves the two major pain points of elderly patients: fear of pain and inability to remember data, "said the R&D leader of
Guilin Royalyze Medical. The device has 200 sets of data storage functions and an automatic test strip design, which not only facilitates doctors to trace the condition, but also avoids the risk of cross infection. Currently, it has been clinically validated in second-class or above hospitals and provides OEM services for multiple well-known brands. With the market size of blood glucose meters in China exceeding 24 billion yuan by 2025, this type of high cost-effective intelligent device is accelerating the process of domestic substitution, and the equipment rate in primary hospitals has increased from 34% to 61%.